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Abstract
Objectives: To assess whether the 16-item Activities-specific Balance Confidence scale (ABC-16) and short-form 6-item Activities-specific
Balance Confidence scale (ABC-6) could predict future recurrent falls in people with Parkinson disease (PD) and to validate the robustness of their
predictive capacities.
Design: Twelve-month prospective cohort study.
Setting: General community.
Participants: People with idiopathic PD (NZ79).
Interventions: Clinical tests were conducted to assess symptom severity, balance confidence, and medical history. Over the subsequent
12 months, participants recorded any falls on daily fall calendars, which they returned monthly by reply paid post.
Main Outcome Measures: Logistic regression and receiver operating characteristic analyses estimated the sensitivities and specificities of the
ABC-16 and ABC-6 for predicting future recurrent falls in this cohort, and “leave-one-out” validation was used to assess their robustness.
Results: Of the 79 patients who completed follow-up, 28 (35.4%) fell more than once during the 12-month period. Both the ABC-16 and ABC-6
were significant predictors of future recurrent falls, and moderate sensitivities (ABC-16: 75.0%; ABC-6: 71.4%) and specificities (ABC-16:
76.5%; ABC-6: 74.5%) were reported for each tool for a cutoff score of 77.5 and 65.8, respectively.
Conclusions: The results have significant implications and demonstrate that the ABC-16 and ABC-6 independently identify patients with PD at
risk of future recurrent falls.
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ª 2016 by the American Congress of Rehabilitation MedicineParkinson disease (PD) is characterized by complex symptoms that
impair physical function and increase the risk of recurrent falls.1
Nearly 65% of people with PD report falling at least once each
year, whereas up to 50% experience recurrent falls.2-4 The increased
prevalence of falls is compounded by impaired postural responses5
that increase the risk of fall-related injuries, injury-related deaths,
and hospitalization.6 Although fall-related injuries often receive
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frequent falls contribute to reduced balance confidence and
increased fear of future falls, which restricts one’s physical activ-
ities and ultimately reduces independence and quality of life.
The 16-item Activities-specific Balance Confidence scale
(ABC-16) has been widely used to assess balance confidence in
people with PD, but the need to accurately and rapidly assess
patient risk in clinical practice often requires more time-efficient
tools. Despite being shorter, the 6-item Activities-specific Balance
Confidence scale (ABC-6) has properties similar to those of the
ABC-16 and, therefore, may be useful in assessing balance
confidence in people with PD.8 Although the Chinese
translated Activities-specific Balance Confidence scale (ABC-C)habilitation Medicine
Table 1 Demographic data, balance confidence, and disease-specific scores for the participants with PD and the recurrent faller and
nonrecurrent faller subgroups
Characteristic
All Patients
(NZ79)
Recurrent
Faller
(nZ28)
Nonrecurrent
Faller
(nZ51) Test P
Demographic characteristics
Age (y) 68.10.9 69.51.6 67.31.1 1 .250
Sex: male 51 (64.6) 20 (71.4) 31 (60.8) 2 .344
Height (cm) 168.21.0 167.21.7 168.81.2 1 .451
Mass (kg) 74.31.8 70.32.9 76.52.2 1 .097
Body mass index (kg/m2) 26.10.5 25.10.9 26.70.7 1 .134
Fall history and balance confidence
ABC-16 77.51.9 67.93.1 82.82.1 3 <.001
ABC-6 67.22.6 55.44.0 73.73.0 3 <.001
Previous falls (12mo) 3.31.4 8.53.8 0.50.1 3 <.001
Neurological examination
Disease duration (y) 6.10.5 8.41.0 4.80.5 3 .006
Levodopa (mg/d) 655.747.5 876.783.3 534.450.7 3 .001
Dopamine agonists 30 (38.0) 12 (42.9) 18 (35.3) 2 .508
Catechol-O-methyl transferase inhibitors 28 (35.4) 13 (46.4) 15 (29.4) 2 .130
Monoamine oxidase inhibitors 12 (15.2) 4 (14.3) 8 (15.7) 2 .868
Benzodiazepine 4 (5.1) 4 (14.3) 0 (0.0) 2 .006
No antiparkinsonian medication 5 (6.3) 0 (0.0) 5 (9.8) 2 .087
UPDRS I 3.20.2 3.40.4 3.00.2 3 .341
UPDRS II 11.30.6 14.01.1 9.80.6 3 .003
UPDRS III 20.21.0 25.11.5 17.61.2 1 <.001
UPDRS IV 3.90.3 5.00.7 3.40.3 3 .035
UPDRS total 34.71.5 42.52.5 30.41.6 1 <.001
PIGD score 4.70.4 6.30.7 3.70.3 3 .003
Freezing of Gait Questionnaire 5.80.6 9.11.0 4.00.5 3 <.001
Hoehn and Yahr stage scale 1.90.1 2.40.1 1.60.1 3 <.001
Schwab and England Activities
of Daily Living Scale
80.91.1 74.61.8 84.31.1 3 <.001
NOTE. Values are mean  SEM or as n (%).
Abbreviations: PIGD, postural instability and gait disability; Test 1, independent samples t test; Test 2, c2 test; Test 3, Mann-Whitney U test.
Screening for fall risk in Parkinson disease 153has been shown to independently predict future recurrent falls in
people with PD,7 it is unclear whether the ABC-16 and ABC-6 are
suitable for screening fall risk in patients with PD. This pro-
spective study aimed to assess whether the ABC-16 and ABC-6
were capable of predicting future recurrent falls in people with
PD and to validate the robustness of their predictive capacities.Methods
Study population
Seventy-nine people with idiopathic PD based on the UK Brain
Bank Criteria9 were recruited from neurology clinics andList of abbreviations:
ABC-6 6-item Activities-specific Balance Confidence scale
ABC-16 16-item Activities-specific Balance Confidence scale
ABC-C Chinese translated Activities-specific Balance Confidence
scale
PD Parkinson disease
ROC receiver operating characteristic
UPDRS Unified Parkinson’s Disease Rating Scale
www.archives-pmr.orgpreexisting patient databases between August 2011 and June 2013.
Participants were excluded if they had (1) recent surgery; (2) a
recurrent history of musculoskeletal injury; (3) an inability to walk
without assistance; (4) significant visual or cognitive impairments;
or (5) received deep brain stimulation. Participants gave written
informed consent in accordance with the Declaration of Helsinki,
and the protocol was approved by the Australian Catholic Uni-
versity’s Human Research Ethics Committee (approval no.
Q2011 04).Clinical assessment
Participants completed questionnaires and clinical assessments to
assess their medical history, symptom severity, and balance con-
fidence. Specifically, symptom severity was assessed using the
Freezing of Gait Questionnaire, Unified Parkinson’s Disease
Rating Scale (UPDRS), Hoehn and Yahr stage scale, and Schwab
and England Activities of Daily Living Scale. The UPDRS is a
universally accepted clinical test comprising 4 subscales that
assess (1) changes in mentation, behavior, or mood; (2) difficulties
with activities of daily living; (3) impairments in motor function;
and (4) therapeutic complications. The Hoehn and Yahr stage
scale assesses the stage of PD on the basis of the severity and
Fig 1 ROC curves for the (A) ABC-16; (B) ABC-6; (C) leave-one-out validation of the ABC-16; and (D) leave-one-out validation of the ABC-6.
154 M.H. Cole et aldistribution of symptoms, with higher scores reflecting a more
advanced disease state. Postural instability and gait difficulties
were quantified by summing the scores for items 13 to 15 and 27
to 30 of the UPDRS, and the ABC-16 and ABC-6 were used to
assess balance confidence. Patients were assessed within 1 to 2
hours of taking their antiparkinsonian medication (table 1).
Twelve-month prospective follow-up
After clinical evaluation, participants recorded any falls experi-
enced over the subsequent year on daily fall calendars that they
returned monthly by reply paid post. To minimize attrition, par-
ticipants were posted a reminder if one of the calendars was not
returned. A fall was defined as an unintentional coming to the
ground or some lower level not as a result of a major intrinsic
event or overwhelming hazard.6Statistical analysis
Independent samples t tests were used to assess differences
between groups for continuous measures of demographic char-
acteristics, symptom severity, and balance confidence. Where
the assumptions of parametric statistics were violated, the
nonparametric Mann-Whitney U test was used. The chi-square test
was used to evaluate associations between the categori-
cal variables.
To determine whether the ABC-16 and ABC-6 could predict
future recurrent falls in people with PD, the sensitivities and
specificities of these assessments were evaluated using logistic
regression and receiver operating characteristic (ROC) analyses.
The best cutoff score on each scale was considered to be optimal in
providing the highest sensitivity and specificity pairing on the ROC
curves. To assess the efficacy of the ABC-16 and ABC-6 to predictwww.archives-pmr.org
Screening for fall risk in Parkinson disease 155future falls in other samples, “leave-one-out” validation was used.
Significance was set at P<.05, and all statistical procedures were
conducted using SPSS 21a and the R statistics package.bResults
Of the 313 patients contacted, 188 did not respond, 22 were not
interested, and 4 were deceased. A further 18 were excluded after
screening: 13 had deep brain stimulation surgery, 3 used a walking
aid, and 2 had poor cognition. The remaining 81 completed all
assessments, but 2 did not complete follow-up. On the basis of
prospective falls, participants were divided into 2 groups: (1)
28 participants (35%) who reported 2 falls during the 12-month
period (recurrent fallers); and (2) 51 participants (65%) who
experienced 1 falls during this period (nonrecurrent fallers).
Compared with nonrecurrent fallers, recurrent fallers had signifi-
cantly longer disease duration, took larger amounts of levodopa,
and experienced greater difficulties with daily activities, physical
function, and mobility (see table 1). Furthermore, recurrent fallers
typically presented with symptoms of more advanced PD, had
lower balance confidence, and experienced more previous falls
and therapeutic complications (eg, dyskinesia) according to part
IV of the UPDRS.
Logistic regression analyses revealed that the ABC-16 (odds
ratio, .95; 95% confidence interval, .92e.98) and ABC-6 (odds
ratio, .96; 95% confidence interval, .94e.99) were both signifi-
cant predictors of recurrent falls in people with PD. Furthermore,
ROC analyses indicated that a cutoff score of 77.5 provided the
best sensitivity (75.0%) and specificity (76.5%) for predicting
future falls with the ABC-16 (fig 1A) whereas a cut-off score of
65.8 provided the best sensitivity (71.4%) and specificity
(74.5%) with the ABC-6 (fig 1B). Validation of these models
marginally reduced the area under the curve for the ABC-16
(fig 1C) and ABC-6 (fig 1D), as well as the specificity of the
ABC-6 (70.6%).Discussion
This is the first study to establish that the ABC-16 and ABC-6 can
independently predict future recurrent falls in people with PD. The
optimal cutoff scores on the ABC-16 (77.5 of 100) and ABC-6
(65.8 of 100) produced moderate to high sensitivities and speci-
ficities, and the validation suggested that both models were robust.
However, these cutoff scores were chosen on the basis of the best
combinations of sensitivity and specificity; hence, different cutoff
scores should be considered if minimizing the likelihood of mis-
classifying “high-risk” patients is important. For example, a cutoff
score of 85.9 on the ABC-16 yielded a sensitivity and specificity
of 85.7% and 52.9%, whereas a cut-off score of 77.5 on the ABC-6
increased sensitivity to 82.1% but reduced specificity to 51.0%.
Interestingly, our cutoff scores were higher than those found in a
previous research7 on the ABC-C, which demonstrated that a score
of 68.4 predicted future recurrent fallers with a sensitivity and
specificity of 87% and 68%. This discrepancy is likely related to 2
factors: (1) the ABC-C modified 4 questions on the ABC-16 that
were considered irrelevant to Chinese people10; and (2) all recurrent
fallers assessed with the ABC-C had previously fallen7 (compared
with 71% in the present study). This higher percentage of previouswww.archives-pmr.orgfallers would likely exacerbate fear of future falls (ie, lower balance
confidence) for these individuals. Given this point, our results may be
limited to the English versions of the ABC-16 and ABC-6 and to
people with PD living independently in the community.
Study limitations
It is important to consider that the transferability of these findings
may be limited because only 25% of the invited patients agreed to
participate. Although it was not possible to compare symptom
severity or balance confidence between the included patients and
those who declined or did not respond, a comparison of the groups
for age (PZ.765), sex distribution (PZ.586), and proximity of the
testing location (PZ.512) showed no significant differences.
Despite these results suggesting that the sample was somewhat
representative of the wider PD community in this geographical
region, it is possible that the reported cutoff scores may not be
suitable for all populations with PD.Conclusions
Nonetheless, these results are clinically significant and demon-
strate that the ABC-16 and short-form ABC-6 are suited to
not only assessing balance confidence in people with PD but
also independently predicting future recurrent falls in this
population.Suppliers
a. IBM Corp.
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